Literature DB >> 4053012

Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II.

M A Burton, B N Gray, G W Self, J C Heggie, P S Townsend.   

Abstract

The effects of angiotensin II on the distribution of blood flow to experimental hepatic tumors in ten rats and rabbits were examined using blood flow tracer microspheres. The ratio of arterially introduced microspheres lodging in tumor tissue compared to the surrounding normal hepatic parenchyma was measured before and after i.v. infusion of angiotensin II-inducing incremental systemic responses. A significant elevation (P less than 0.05) in this ratio was described for both rats (3.0-fold) and rabbits (3.2-fold) following the drug infusion. Ratio elevation occurred in 37 of 40 tumors examined despite the lack of a clear dose-response relationship. In addition, angiotensin II was found to significantly (P less than 0.05) increase the number of microspheres gaining arterial access to the central portions of the tumors. In terms of internal radiation therapy, these results would indicate a substantially enhanced radiation dose reaching tumor tissue after angiotensin II infusion, while relatively sparing the surrounding normal tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4053012

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Modification of tumor blood flow and enhancement of therapeutic effect of ACNU on experimental rat gliomas with angiotensin II.

Authors:  K Tokuda; H Abe; T Aida; S Sugimoto; S Kaneko
Journal:  J Neurooncol       Date:  1990-06       Impact factor: 4.130

2.  Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging.

Authors:  H Sato; K Sugiyama; M Hoshi; M Urushiyama; K Ishizuka
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

3.  Modification of tumour blood flow using the hypertensive agent, angiotensin II.

Authors:  G M Tozer; K M Shaffi
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

4.  Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.

Authors:  C Jones; M A Burton; B N Gray
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

Review 5.  Hepatic arterial chemotherapy for metastatic colorectal carcinoma.

Authors:  P G de Takats; D J Kerr; C J Poole; H W Warren; C S McArdle
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

6.  Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.

Authors:  M J Dworkin; P Carnochan; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour.

Authors:  J A Goldberg; T Murray; D J Kerr; N Willmott; R G Bessent; J H McKillop; C S McArdle
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

8.  Redistribution of blood flow in experimental hepatic tumours with noradrenaline and propranolol.

Authors:  M A Burton; B N Gray
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

9.  Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.

Authors:  M J Dworkin; P Carnochan; T G Allen-Mersh
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

Review 10.  Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.

Authors:  Etienne Garin; Yan Rolland; Sophie Laffont; Julien Edeline
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.